Borg Pharma Limited - Accounts to registrar (filleted) - small 18.1

Borg Pharma Limited - Accounts to registrar (filleted) - small 18.1


IRIS Accounts Production v18.1.1.51 06346407 Board of Directors 1.9.16 31.8.17 31.8.17 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure063464072016-08-31063464072017-08-31063464072016-09-012017-08-31063464072015-08-31063464072015-09-012016-08-31063464072016-08-3106346407ns15:EnglandWales2016-09-012017-08-3106346407ns14:PoundSterling2016-09-012017-08-3106346407ns10:Director12016-09-012017-08-3106346407ns10:PrivateLimitedCompanyLtd2016-09-012017-08-3106346407ns10:SmallEntities2016-09-012017-08-3106346407ns10:AuditExempt-NoAccountantsReport2016-09-012017-08-3106346407ns10:SmallCompaniesRegimeForDirectorsReport2016-09-012017-08-3106346407ns10:SmallCompaniesRegimeForAccounts2016-09-012017-08-3106346407ns10:FullAccounts2016-09-012017-08-310634640712016-09-012017-08-3106346407ns10:Director22016-09-012017-08-3106346407ns10:Director32016-09-012017-08-3106346407ns10:CompanySecretary12016-09-012017-08-3106346407ns10:RegisteredOffice2016-09-012017-08-3106346407ns5:CurrentFinancialInstruments2016-08-3106346407ns5:CurrentFinancialInstruments2017-08-3106346407ns5:ShareCapital2016-08-3106346407ns5:ShareCapital2017-08-3106346407ns5:RetainedEarningsAccumulatedLosses2016-08-3106346407ns5:RetainedEarningsAccumulatedLosses2017-08-3106346407ns5:NetGoodwill2016-09-012017-08-3106346407ns5:IntangibleAssetsOtherThanGoodwill2016-09-012017-08-3106346407ns5:PlantMachinery2016-09-012017-08-3106346407ns5:NetGoodwill2016-08-3106346407ns5:NetGoodwill2017-08-3106346407ns5:NetGoodwill2016-08-3106346407ns5:PlantMachinery2016-08-3106346407ns5:PlantMachinery2017-08-3106346407ns5:PlantMachinery2016-08-3106346407ns5:CostValuation2016-08-3106346407ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-08-3106346407ns5:CurrentFinancialInstrumentsns5:WithinOneYear2016-08-31


REGISTERED NUMBER: 06346407 (England and Wales)










Unaudited Financial Statements for the Year Ended 31 August 2017

for

Borg Pharma Limited

Borg Pharma Limited (Registered number: 06346407)






Contents of the Financial Statements
for the Year Ended 31 August 2017




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Borg Pharma Limited

Company Information
for the Year Ended 31 August 2017







DIRECTORS: P Khiroya
N Nathwani
K Patel





SECRETARY: P Khiroya





REGISTERED OFFICE: Unit 4 Wintonlea
Monument Way West
Woking
Surrey
GU21 5EN





REGISTERED NUMBER: 06346407 (England and Wales)





ACCOUNTANTS: NSO Associates LLP
75 Springfield Road
Chelmsford
Essex
CM2 6JB

Borg Pharma Limited (Registered number: 06346407)

Balance Sheet
31 August 2017

31.8.16 31.8.17
£    £    Notes £    £   
FIXED ASSETS
112,380 Intangible assets 4 48,030
8,656 Tangible assets 5 3,613
3 Investments 6 695
121,039 52,338

CURRENT ASSETS
189,883 Stocks 202,735
499,312 Debtors 7 584,726
657,945 Cash at bank 723,861
1,347,140 1,511,322
CREDITORS
619,439 Amounts falling due within one year 8 639,468
727,701 NET CURRENT ASSETS 871,854
848,740 TOTAL ASSETS LESS CURRENT
LIABILITIES

924,192

1,571 PROVISIONS FOR LIABILITIES 722
847,169 NET ASSETS 923,470

CAPITAL AND RESERVES
3 Called up share capital 3
847,166 Retained earnings 923,467
847,169 SHAREHOLDERS' FUNDS 923,470

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2017.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2017 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

Borg Pharma Limited (Registered number: 06346407)

Balance Sheet - continued
31 August 2017


The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 29 May 2018 and were signed on its behalf by:





P Khiroya - Director


Borg Pharma Limited (Registered number: 06346407)

Notes to the Financial Statements
for the Year Ended 31 August 2017

1. STATUTORY INFORMATION

Borg Pharma Limited is a private company, limited by shares , registered in England and Wales. The company's
registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,
value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2008, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost
less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 50% on cost and 33% on cost

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow
moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to
the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that
have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the
timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they
will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Borg Pharma Limited (Registered number: 06346407)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2017

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the
lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 25 (2016 - 25 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 September 2016
and 31 August 2017 779,000
AMORTISATION
At 1 September 2016 666,620
Charge for year 64,350
At 31 August 2017 730,970
NET BOOK VALUE
At 31 August 2017 48,030
At 31 August 2016 112,380

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 September 2016
and 31 August 2017 182,087
DEPRECIATION
At 1 September 2016 173,431
Charge for year 5,043
At 31 August 2017 178,474
NET BOOK VALUE
At 31 August 2017 3,613
At 31 August 2016 8,656

Borg Pharma Limited (Registered number: 06346407)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2017

6. FIXED ASSET INVESTMENTS

31.8.17 31.8.16
£    £   
Shares in group undertakings 3 3
Other investments not loans 692 -
695 3

Additional information is as follows:
Shares in
group
undertakings
£   
COST
At 1 September 2016
and 31 August 2017 3
NET BOOK VALUE
At 31 August 2017 3
At 31 August 2016 3

Investments (neither listed nor unlisted) were as follows:
31.8.17 31.8.16
£    £   
Vehicle number plate 692 -

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.17 31.8.16
£    £   
Trade debtors 453,301 393,046
Other debtors 131,425 106,266
584,726 499,312

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.17 31.8.16
£    £   
Trade creditors 496,023 436,441
Taxation and social security 24,892 60,222
Other creditors 118,553 122,776
639,468 619,439